HIV and Secondary Immunodeficiency Flashcards

1
Q

What are some causes of secondary immune deficiency?

A
  1. Malnutrition
  2. Drugs
  3. 2nd to infections: Mesales, TB, HIV, potentialls SARS-CoV-2
  4. ageing, genetic metabolic disease etc. etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the most common drugs causing immune supression?

A
  1. Steroids (Gluco + Mineralcorticoids)
  2. Cytotoxic agents (MTX, azathioprine, others)
  3. Calcineurin inhibitors (cyclosporine, tacrolimus)
  4. Antiepileptic drugs (phenytoin, carbamazepine, levetiracetam)
  5. DMARD
  6. Other Biologics and Cellular therapies (e.g. JAK inhibitors: tofacitttinib, other new biologics)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What should be co-prescribed when prescribing rituximab chemotherapy/ other anti-CD20 drugs?

A

Usually with PCP prophylaxis due to increased risk of fungal infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do biological treatments (especially anti-CD20 agents) cause immunodeficiency?

A

Leading to antibody deficiency –> (increased risk of bacterial/viral/fungal infections)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What lab tests should be done to investigate secondary immunodeficiency?

A

FISH analysis (recap)

  1. FBC
  2. Immunoglobulins (IgG, A M, E)
  3. Serum complements (C3,4)
  4. HIV test
    –> will pick up cause of 85% of immunodeficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What first line chemical blood test should be done in a pateint with 2nd immunodeficiency?

A
  • Renal+Liver profile (incl. urine cr ratio, albumin)
  • Calcium and bone
  • Serum free light chains + electrophoresis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does an isolated reduction in IgG suggests?

A
  1. Protein loosing enteropathy
  2. Prednisolone >10mg/day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does a reduction in IgG and IgM on serum immunoglobulins suggest?

A

Monitor for B cell neoplasm
? History of exposure of rituximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What might a reductionin IgG and IgA suggest?

A

? Primary antibody deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why would you measure vaccine antibody concentration in investigation for immune deficiency?

A

Usually measure
1. tetanus toxoid protein antigen
2. Pneumovax: T-cell independent production of antibodies

Measure to see if promary antibody deficiency syndromes+ needed as criteria for replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are conservative measurements to manage secondary immune deficiency?

A
  • reduce exposure to infection
  • immunisation + immunisation of household contacts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is medical management of secondary immune deficiency?

A
  1. Early + longer ABx treatment of bacterial infection
  2. Prophylactic ABx
  3. Potentially IgG replacement therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the criteria for IgG replacement therapy in secondary antibody deficiency syndromes?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the difference between HIV 1 and HIV 2?

A

HIV1 : most common species worldwide
HIV-2: restricted almost completely to West Africa –> slightly less transmission and slower progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the key characteristics oft the HI-virus?

A
  • double-stranded RNA virus
  • retrovirus –> integration into host genome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the effects of untreated HIV infectionon in the lymph nodes?

A

Disruption of lympho node architecture + impaired ability to generatet protective T cand Be cell immune response

17
Q

Explain the natural progression of HIV infections regarding
1. Viral load
2. CD4 counts
3. Immune activation

A

Usually acute infection followed by chornic phase (~10 years)
10% are rapid progressors (2-3 years)

  1. Viral Load: Very high in acute infection (2-14 weeks post-transmission), then decreases in latent phase and increases again in AIDS
  2. CD4 counts: small dip initially, but then recovers and only dips in AIDS/ symptomatic chronic period
18
Q

How is HIV testes for?

A

Now Screening with
4th generation combined HIV-1 antibody/antigen test
(positive 1 month post-aquisition)
(others are also possible: e.g. Viral RNA, rapid point of care testing)

Viral RNA testing if

  • negative test but high clinical suspicion
  • in babys under 18 months due to AB transfere from mother

Followed by confirmatory testing if positive
* Repeat 4th generation test
* do HIV 1/2 differentiation immunoassay

19
Q

What are the main characteristics of an acute HIV infection?
1. Clinically
2. Bloods (RNA;, CD4 and CD8 counts)

A
  1. Clinically: flu like symptoms (in 70%), lymphadenopathy, rash, GI symptoms

Bloods:
- RNA: very high (high risk of transmission)
- CD4 decrease
- CD8 increase (coincides with drop in Viral load)

20
Q

What baseline investigations should be done in a patient just diagnosed with HIV?

A

+ HIV Viral load and HIV genotypes (next generation sequencing)
+ T-cell count (CD4 cound and CD4 : CD8 cell ratio)

21
Q

What diseases are you predisposed to with a CD4 count <500?

A

Bacterial Skin infections
HSV Zoster
Fungal infections (skin, oral)

22
Q

What diseases are you predisposed to with a CD4 count <400?

A

kaposi’s sarcoma

23
Q

What diseases are you predisposed to with a CD4 count <300?

A

Hariy Leukoplakia
Tuberculosis

24
Q

What diseases are you predisposed to with a CD4 count <200?

A

PCP/PJP
Cryptococcis
Toxoplasmosis

25
Q

What diseases are you predisposed to with a CD4 count <100?

A

CMV
Lymphoma (EBV)

26
Q

Explain the principles and treatment regiment for HIV infection

A

Initiation of treatment on triple therapy

Triple therapy
* Two NRTI + 3rd drug of a different class, e.g.
* (usually protease inhibitor or NNRTI)